DK53485D0 - Fremgangsmaade til passiv immunisering af pattedyr under anvendelseaf fugle- og/eller bovidantistof og midler hertil - Google Patents

Fremgangsmaade til passiv immunisering af pattedyr under anvendelseaf fugle- og/eller bovidantistof og midler hertil

Info

Publication number
DK53485D0
DK53485D0 DK53485A DK53485A DK53485D0 DK 53485 D0 DK53485 D0 DK 53485D0 DK 53485 A DK53485 A DK 53485A DK 53485 A DK53485 A DK 53485A DK 53485 D0 DK53485 D0 DK 53485D0
Authority
DK
Denmark
Prior art keywords
bovidant
bird
agents
procedure
materials
Prior art date
Application number
DK53485A
Other languages
English (en)
Other versions
DK53485A (da
DK166905B1 (da
Inventor
Ralph J Stolle
Lee R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of DK53485D0 publication Critical patent/DK53485D0/da
Publication of DK53485A publication Critical patent/DK53485A/da
Application granted granted Critical
Publication of DK166905B1 publication Critical patent/DK166905B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK053485A 1984-02-07 1985-02-06 Middel, der kan anvendes til passiv heterolog immunisering af et pattedyr DK166905B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57780484A 1984-02-07 1984-02-07
US57780484 1984-02-07
US06/622,130 US4748018A (en) 1984-02-07 1984-06-19 Method of passive immunization of mammals using avian antibody
US62213084 1984-06-19

Publications (3)

Publication Number Publication Date
DK53485D0 true DK53485D0 (da) 1985-02-06
DK53485A DK53485A (da) 1985-08-08
DK166905B1 DK166905B1 (da) 1993-08-02

Family

ID=27077340

Family Applications (2)

Application Number Title Priority Date Filing Date
DK053485A DK166905B1 (da) 1984-02-07 1985-02-06 Middel, der kan anvendes til passiv heterolog immunisering af et pattedyr
DK227190A DK227190D0 (da) 1984-02-07 1990-09-20 Fremgangsmaade til passiv immunisering af pattedyr under anvendelse af bovid-antistof og midler hertil

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK227190A DK227190D0 (da) 1984-02-07 1990-09-20 Fremgangsmaade til passiv immunisering af pattedyr under anvendelse af bovid-antistof og midler hertil

Country Status (11)

Country Link
US (1) US4748018A (da)
EP (2) EP0152270B1 (da)
JP (6) JP2548115B2 (da)
AT (1) ATE135016T1 (da)
CA (3) CA1275044A (da)
DE (1) DE3504221C2 (da)
DK (2) DK166905B1 (da)
GR (1) GR850323B (da)
IE (1) IE64365B1 (da)
IL (1) IL74155A (da)
NZ (1) NZ211030A (da)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
US5932250A (en) * 1982-06-03 1999-08-03 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
ES2052496T3 (es) * 1985-11-25 1994-07-16 Ghen Corp Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso.
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
US5565550A (en) * 1987-05-04 1996-10-15 Dana Farber Cancer Institute Antibodies to ICAM-2, and fragments thereof
JP2641228B2 (ja) * 1988-01-22 1997-08-13 鐘紡株式会社 抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法
US5059419A (en) * 1988-06-09 1991-10-22 Grand Laboratories, Inc. Streptococcus suis antiserum and its use in treating Streptococcus suis infections
JP2689511B2 (ja) * 1988-08-18 1997-12-10 ライオン株式会社 食 品
US6511664B1 (en) 1989-03-09 2003-01-28 Dana Farber Cancer Institute Intercellular adhesion molecule—2 and its binding ligands
US6932968B1 (en) 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
US7005560B1 (en) * 1989-10-27 2006-02-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5196193A (en) * 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
US5958413A (en) * 1990-11-01 1999-09-28 Celltech Limited Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
JP2553445B2 (ja) * 1992-12-17 1996-11-13 同仁医薬化工株式会社 抗体の安定化方法
JPH09500870A (ja) * 1993-05-26 1997-01-28 ストール・リサーチ・アンド・ディベロップメント・コーポレイション 抗‐コレステロール血症卵、ワクチンならびにその製法および使用
US6068862A (en) * 1993-06-30 2000-05-30 Taiyo Kagaku Co., Ltd. Tea-derived feed additive and animal feed containing the same
AU1518595A (en) * 1994-01-14 1995-08-01 Genentech Inc. Antagonists to insulin receptor tyrosine kinase inhibitor
EP0749321B1 (en) * 1994-02-09 2007-01-24 Epitopix LLC Active immunization using a siderophore receptor protein
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US5814316A (en) * 1994-08-05 1998-09-29 Wisconsin Alumni Research Foundation Compound to mimick a naturally occurring peptide's effect
ATE337792T1 (de) * 1994-08-05 2006-09-15 Wisconsin Alumni Res Found Verwendung von gegen ein darmpeptid gerichtete antikörper zur förderung der futterverwertung
US5939269A (en) * 1994-12-28 1999-08-17 The Regents Of The University Of California Antagonists to insulin receptor tyrosine kinase inhibitor
AU5431196A (en) * 1995-03-24 1996-10-16 Ophidian Pharmaceuticals Treatment for verotoxin-producing escherichia coli
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
WO1997033915A1 (de) * 1996-03-12 1997-09-18 Ovoimmun Gmbh Aviäre, vitelline, gegen hiv-antigene gerichtete antikörper
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
US5725873A (en) * 1996-07-22 1998-03-10 Wisconsin Alumni Research Foundation Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
EP0930891A4 (en) * 1996-10-02 2001-07-04 Ovimmune Inc ORAL ADMINISTRATION OF CHICKEN EGG ANTIBODIES FOR TREATING DISEASES
JP3430853B2 (ja) 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
JPH10298105A (ja) * 1997-04-23 1998-11-10 Gen Corp:Kk 腸管出血性大腸菌による感染症の予防剤および治療剤
WO1998055143A1 (en) * 1997-06-04 1998-12-10 The Arizona Board Of Regents On Behalf Of The University Of Arizona Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
US6086878A (en) * 1997-08-21 2000-07-11 Dcv, Inc. Method of increasing muscle protein and reducing fat in animals
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US6395273B1 (en) * 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
JP2000351735A (ja) * 1999-04-09 2000-12-19 Akzo Nobel Nv カンピロバクターワクチン
US7241443B1 (en) * 1999-07-15 2007-07-10 Camas Incorporated Immunogen adherence inhibitor and method of making and using same
US7238351B2 (en) * 1999-07-15 2007-07-03 Peter Nash Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
AU6726500A (en) * 1999-08-24 2001-03-19 Nomoto, Kikuo Methods of pasteurizing immune substance containing antiinflammatory factor and utilization thereof
US6706267B1 (en) 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
WO2001072141A2 (en) * 2000-03-24 2001-10-04 Trouw Nutrition Usa Combination of plasma and hyperimmunized products for increased performance of weanlings
CA2433561C (en) * 2001-01-03 2014-04-01 Willmar Poultry Company, Inc. Compositions including gram negative siderophore receptor proteins and methods of use
CA2339436A1 (fr) * 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
WO2002094124A2 (en) * 2001-05-18 2002-11-28 Arkion Life Sciences Method of increasing uniformity in avians
US20030003104A1 (en) * 2001-07-02 2003-01-02 John Mottola Method for removal of pathogens from a localized environment
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
AU2002246753B8 (en) * 2001-12-28 2009-09-24 Camas, Incorporated Organism adherence inhibitor and method of making and using same
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
US7083809B2 (en) * 2002-02-11 2006-08-01 Arkion Life Sciences, Llc Purified cytokine inhibitory factor
US20040005327A1 (en) * 2002-05-16 2004-01-08 Subramanian Iyer Immune T-cell stimulation
US6729265B2 (en) * 2002-06-27 2004-05-04 Arkion Life Sciences Llc Supplemented antibody feed to enter the circulating system of newborns
US9701737B2 (en) * 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
ES2371395T3 (es) * 2003-02-19 2011-12-30 Camas Incorporated Inhibidor de adherencia de inmunógenos y procedimiento de preparación y uso del mismo.
US20110274701A1 (en) * 2010-05-07 2011-11-10 Camas Incorporated Composition and method for preventing/decreasing respiratory illness
WO2005003173A1 (en) * 2003-07-07 2005-01-13 Luiz Fernando Mesquita Process of obtaining a freeze-dried complex from mammal gland secretion
ES2395022T3 (es) * 2003-09-19 2013-02-07 Epitopix, Llc Polipéptidos de Campylobacter y sus métodos de uso
WO2005099753A1 (en) * 2004-04-16 2005-10-27 The Govenors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
AU2006285306B2 (en) * 2005-07-25 2012-07-19 Avianax, Llc. Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
US8877187B2 (en) * 2005-07-25 2014-11-04 Avianax, Llc Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
US20070264264A1 (en) * 2005-08-30 2007-11-15 La Belle Associates, Inc. Method and composition for conferring immunity in mammals
CA2521156A1 (en) * 2005-09-16 2007-03-16 John Hare Antibodies as growth promoting agents
EP1790358A1 (en) * 2005-11-23 2007-05-30 Université de Reims Champagne-Ardennes Protein constructs designed for targeting and lysis of cells
US20090317421A1 (en) 2006-01-18 2009-12-24 Dominique Missiakas Compositions and methods related to staphylococcal bacterium proteins
JP4753808B2 (ja) * 2006-06-20 2011-08-24 アサマ化成株式会社 感染症予防食品添加用組成物
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
US8282928B2 (en) * 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
HUE032078T2 (en) 2007-07-09 2017-08-28 Nestec Sa Procedure for reducing allergies caused by environmental allergens
EP2185190B1 (en) 2007-08-31 2015-06-24 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US20110166328A1 (en) * 2008-09-02 2011-07-07 Huan Nguyen Avian Antibodies Specific to Influenza Virus and Technologically Simple Methods of Their Manufacture and Use
EP2341929B1 (en) 2008-10-06 2017-01-25 University Of Chicago Compositions and methods related to bacterial emp proteins
ES2784957T3 (es) 2009-04-03 2020-10-02 Univ Chicago Composiciones y métodos relacionados con variantes de la proteína A (SPA)
EA024697B1 (ru) 2009-04-27 2016-10-31 Иммурон Лимитед Применение композиции, содержащей обогащенный анти-lps-антителами иммуноглобулиновый препарат, для лечения заболеваний печени
US10266585B2 (en) 2009-08-28 2019-04-23 The Board Of Regents Of The Univerity Of Texas System Methods of treating brain injury
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
JP6002128B2 (ja) 2010-07-02 2016-10-05 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ プロテインＡ（ＳｐＡ）変種に関連する組成物および方法
CA2808361A1 (en) 2010-08-17 2012-02-23 Immuron Ltd. Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of inflammatory bowel disease
US9095540B2 (en) 2010-09-09 2015-08-04 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
MX340019B (es) * 2010-11-23 2016-06-22 Pantheryx Inc Composiciones y metodos para el tratamiento en aplicaciones clinicas de amplio espectro, no diferenciadas o combinadas.
DE102011006781A1 (de) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antikörperprodukt, umfassend n spezifische Antikörper
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
BR112014003315A2 (pt) 2011-08-15 2017-03-01 Univ Chicago composições e métodos relacionados a anticorpos para a proteína a estafilocócica
AU2013252883B2 (en) 2012-04-26 2018-05-17 University Of Chicago Staphylococcal coagulase antigens and methods of their use
EP2841101B1 (en) 2012-04-26 2019-08-07 University Of Chicago Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
US10125373B2 (en) 2013-01-22 2018-11-13 Arizona Board Of Regents On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
EP2986316B1 (en) 2013-04-19 2023-01-25 Immuron Limited Methods and compositions for the treatment and/or prophylaxis of clostridium difficile associated disease
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
US11246924B2 (en) 2016-04-01 2022-02-15 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
WO2019183500A1 (en) 2018-03-23 2019-09-26 Hung Chiung Yu Coccidioides antigens and methods of their use
US11339387B2 (en) 2018-05-22 2022-05-24 The Government Of The United States Of America As Represented By The Secretary Of Homeland Security Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
US12263192B2 (en) 2019-02-26 2025-04-01 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract
MX2021013833A (es) 2019-05-14 2022-03-17 Univ Chicago Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa).
US11701423B2 (en) 2021-03-12 2023-07-18 Lay Sciences, Inc. Hyperimmunized egg product for treatment or prevention of coronavirus infection
US12435125B2 (en) 2021-04-16 2025-10-07 Prodigy Biotech Hyperimmunized egg product for treating or preventing alcoholic liver disease and graft- versus-host disease
EP4308158A1 (en) 2021-05-17 2024-01-24 Société des Produits Nestlé S.A. Cat food supplements comprising an anti-fel-d1 molecule and an animal digest
EP4514848A1 (en) 2022-04-27 2025-03-05 Lay Sciences, Inc. Targeted anti-sglt1 avian igy antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes
WO2023220243A1 (en) 2022-05-13 2023-11-16 Prodigy Biotech, Inc. Formulations for oral delivery of polypeptides, antibodies and proteins and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
US3646193A (en) * 1969-07-25 1972-02-29 Joseph B Michaelson Iga antibody from lacteal fluids
CH590064A5 (da) * 1973-11-28 1977-07-29 Biokema Sa
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
GB2057451B (en) * 1979-09-05 1983-05-05 South African Inventions Immunological preparations comprising egg yolk antibodies
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit

Also Published As

Publication number Publication date
CA1276883C (en) 1990-11-27
AU3829685A (en) 1985-08-15
JPH04352729A (ja) 1992-12-07
JP2698779B2 (ja) 1998-01-19
EP0152270A3 (en) 1988-01-27
IL74155A0 (en) 1985-04-30
JPH08231426A (ja) 1996-09-10
JP2698778B2 (ja) 1998-01-19
DK227190A (da) 1990-09-20
US4748018A (en) 1988-05-31
AU583808B2 (en) 1989-05-11
CA1276884C (en) 1990-11-27
JP2543633B2 (ja) 1996-10-16
IE64365B1 (en) 1995-07-26
DK53485A (da) 1985-08-08
EP0152270B1 (en) 1992-09-16
JP2723870B2 (ja) 1998-03-09
DK227190D0 (da) 1990-09-20
HK1000183A1 (en) 1998-01-23
DE3504221C2 (de) 1994-05-19
DK166905B1 (da) 1993-08-02
EP0395120A2 (en) 1990-10-31
JPH08231424A (ja) 1996-09-10
EP0395120B1 (en) 1996-03-06
ATE135016T1 (de) 1996-03-15
DE3504221A1 (de) 1985-12-19
IL74155A (en) 1989-06-30
JP2690476B2 (ja) 1997-12-10
JPH08231425A (ja) 1996-09-10
GR850323B (da) 1985-06-06
JPH08231427A (ja) 1996-09-10
EP0395120A3 (en) 1990-12-19
EP0152270A2 (en) 1985-08-21
JP2548115B2 (ja) 1996-10-30
CA1275044A (en) 1990-10-09
JPS60248628A (ja) 1985-12-09
NZ211030A (en) 1989-11-28
IE850289L (en) 1985-08-07

Similar Documents

Publication Publication Date Title
DK53485A (da) Fremgangsmaade til passiv immunisering af pattedyr under anvendelseaf fugle- og/eller bovidantistof og midler hertil
DK0726705T3 (da) Apparat til tidlig embryonal injektion in ovo
ES516797A0 (es) Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.
IT8167356A0 (it) Dispositivo automatico di iniezione particolarmente per la vaccinazione di animali
DK23183A (da) Fremgangsmaade til fremstilling af humane monoclonale antistoffer
ES506659A0 (es) Un metodo para la preparacion de un elastomero de silicona fluorado mejorado.
DK0584715T3 (da) Fremgangsmåde til isolering og dyrkning af transformerede celler og anvendelse af disse til fremstilling af antistoffer ret
Gasbarre et al. Humoral and cellular immune responses in cattle and sheep inoculated with Sarcocystis
DK337479A (da) Fremgangsmaade til at modificere de antigeniske egenskaber hoset quercitindel-holdigt graespollen-antigen eller fragment deraf
NO873774D0 (no) Monoklonale eller polyklonale antistoffer.
DE3785033D1 (de) Verfahren zum erhalten von immunregulierenden faktoren mittels saeugetierimmunisierung.
BR7706417A (pt) Fracao de antigeno de ovo de esquistossomo,processo para sua obtencao,e processo para determinacao da presenca de anticorpos em ovos de esquistossomo amadurecido,em um soro de paciente
IT8026986A0 (it) Antigene di prostata umana purificato e procedimento per preparare anticorpi correlati a tale antigene.
Kofler et al. Immunofluorescence studies on the codistribution immune deposits and complement in the thyroid glands of Obese strain (OS) chickens
CA2008808A1 (en) Vaccine composition
Lehner et al. Attempted immunisation of laboratory animals with metabolic antigens of Fasciola hepatica
DK374879A (da) Fremgangsmaade til fremstilling af alfa-arylalfa,alfa-bis (omega-(disubstitueret amino)alkyl)-acetamider
SE7901565L (sv) Medel for immunisering
Hanna et al. Fasciola hepatica: antibody levels in sheep serum before and after treatment with anthelmintic
Fernando et al. Immunoglobulin classes of antibodies in the sera of buffaloes infected with Toxocara vitulorum
BR8106866A (pt) Aparelho para a disposicao de um ovo
Koldovsky Antigenic Changes During Embryonic Development
SE8305667L (sv) Adenokarcinomrelaterade nya antigena determinanter och antikroppar som er specifika for dessa, forfarande for deras framstellning samt reagenssystem henforande sig till dem
IT8383483A0 (it) Batteria di contenitori per la deposizione di uova di galline.
IT8248853A0 (it) Metodologia per la preparazione dell'antigene toxotossina adsorbito su emazie di montone

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired